Advertisement
UK markets closed
  • FTSE 100

    8,317.59
    -21.64 (-0.26%)
     
  • FTSE 250

    20,770.93
    +139.63 (+0.68%)
     
  • AIM

    810.02
    +5.00 (+0.62%)
     
  • GBP/EUR

    1.1737
    +0.0000 (+0.00%)
     
  • GBP/USD

    1.2739
    +0.0041 (+0.32%)
     
  • Bitcoin GBP

    54,175.63
    +905.89 (+1.70%)
     
  • CMC Crypto 200

    1,445.71
    -22.39 (-1.52%)
     
  • S&P 500

    5,304.72
    +36.88 (+0.70%)
     
  • DOW

    39,069.59
    +4.33 (+0.01%)
     
  • CRUDE OIL

    77.80
    +0.93 (+1.21%)
     
  • GOLD FUTURES

    2,335.20
    -2.00 (-0.09%)
     
  • NIKKEI 225

    38,646.11
    -457.11 (-1.17%)
     
  • HANG SENG

    18,608.94
    -259.77 (-1.38%)
     
  • DAX

    18,693.37
    +2.05 (+0.01%)
     
  • CAC 40

    8,094.97
    -7.36 (-0.09%)
     

Japan Biosimilars Business and Investment Opportunities Report 2023: Market Size is Expected to Record a CAGR of 29.2% During 2023-2027 to Reach US$3,203.6 Million by 2027

Company Logo
Company Logo

Dublin, May 05, 2023 (GLOBE NEWSWIRE) -- The "Japan Biosimilars Business and Investment Opportunities Databook - Q1 2023 Update" report has been added to ResearchAndMarkets.com's offering.

Japan's biosimilar market size is expected to record a CAGR of 29.2% during 2023-2027 to reach US$3,203.6 million by 2027, increasing from US$1,149.7 million in 2023. Over the last five years, the sector has recorded a CAGR of 28.4%.

This report provides an in-depth data-centric analysis of the emerging opportunities in the biosimilars industry. It covers a detailed view of market size and forecast across various segments such as by product, type of cell, imaging technique, procedure, source of manufacturing, applications, type of technology, and end users.

Reasons to Buy

  • In-depth understanding of biosimilars market dynamics: Understand market opportunity, industry dynamics, key trends and drivers across different market segments and sub-segments of the industry in Japan.

  • Develop market-specific strategies: Identify growth segments and target specific opportunities to formulate your investment strategy; assess market-specific key trends, drivers, and risks in the industry.

  • Get market share analysis by end users: Get a detailed analysis across different end users such as hospitals & clinics, diagnostic centres within the Japan.

ADVERTISEMENT

Report Scope

Biosimilar Market Size By Product

  • Monoclonal Antibody Biosimilars

  • Insulin Biosimilar

  • Biosimilar Interferons

  • Other Biosimilar

Biosimilar Market Size By Type of Cell

  • Mammalian

  • Non-Mammalian

Biosimilar Market Size By Imaging Technique

  • Magnetic Resonance Imaging Scanners

  • Computed Tomography Scanners

  • Positron Emission Tomography Scanners

  • Others

Biosimilar Market Size By Procedure

  • Invasive

  • Non-Invasive

Biosimilar Market Size By Source of Manufacturing

  • In-House

  • Contract Manufacturing

Biosimilar Market Size By Applications

  • Oncology

  • Blood Disorders

  • Growth Hormonal Deficiency

  • Chronic & Autoimmune Disorders

  • Infectious Diseases

  • Others

Biosimilar Market Size By Type of Technology

  • Mass Spectroscopy

  • Chromatography

  • Recombinant DNA technology

  • Electrophoresis

  • Others

Biosimilar Market Size By End User

  • Hospital & Clinics

  • Diagnostic Centres

  • Others

For more information about this report visit https://www.researchandmarkets.com/r/pn2c1i

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900